TTY Biopharm Co Ltd (4105) — Financial Flexibility Index
TTY Biopharm Co Ltd (4105) has a Financial Flexibility Index of 0.25x as of December 2025. Free cash flow of NT$813.61 Million (operating CF NT$778.89 Million minus capex NT$34.72 Million) represents 0% of total liabilities (NT$3.30 Billion). Also explore net asset growth rate of TTY Biopharm Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TTY Biopharm Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for TTY Biopharm Co Ltd across 9 annual periods. Check how strategically is TTY Biopharm Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for TTY Biopharm Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for TTY Biopharm Co Ltd. For the full company profile including market capitalisation, see TTY Biopharm Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | NT$1.91 Billion | NT$1.76 Billion | NT$3.30 Billion | ▲ +31.1% |
| 2024 | 0.44x | NT$1.48 Billion | NT$1.35 Billion | NT$3.35 Billion | ▲ +25.8% |
| 2023 | 0.35x | NT$1.18 Billion | NT$1.09 Billion | NT$3.37 Billion | ▼ -13.6% |
| 2022 | 0.41x | NT$1.37 Billion | NT$1.24 Billion | NT$3.37 Billion | ▲ +8.0% |
| 2021 | 0.38x | NT$1.33 Billion | NT$1.26 Billion | NT$3.53 Billion | ▲ +74.7% |
| 2020 | 0.22x | NT$708.21 Million | NT$526.35 Million | NT$3.28 Billion | ▼ -43.0% |
| 2019 | 0.38x | NT$1.28 Billion | NT$1.21 Billion | NT$3.38 Billion | ▼ -12.3% |
| 2018 | 0.43x | NT$1.15 Billion | NT$1.07 Billion | NT$2.66 Billion | ▲ +33.9% |
| 2017 | 0.32x | NT$1.09 Billion | NT$996.52 Million | NT$3.40 Billion | — |